Saghi Esfandiarifard

Saghi Esfandiarifard practices at The Oncology Institute - Downey Radiation Oncology in Cerritos, California.

Saghi Esfandiarifard's NPI, 1992167076, was assigned on March 28, 2016. Saghi Esfandiarifard graduated from St. George's University School of Medicine in 2016. Saghi Esfandiarifard holds California license A160963.

Saghi Esfandiarifard's primary practice is The Oncology Institute - Downey Radiation Oncology, at 18000 Studebaker Rd, Cerritos, CA 90703 in Los Angeles County. The practice phone is (310) 945-8112.

Saghi Esfandiarifard's primary practice is The Oncology Institute - Downey Radiation Oncology in Cerritos, California. Saghi Esfandiarifard is also affiliated with Dignity Health - Northridge Hospital Medical Center. The medical group on file is The Oncology Institute of Hope and Innovation. Dmand AI also links Saghi Esfandiarifard to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Saghi Esfandiarifard practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Saghi Esfandiarifard's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Saghi Esfandiarifard is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Saghi Esfandiarifard's licenses on file in 2 states: California and New York.

CMS data shows 753 Medicare services from Saghi Esfandiarifard across 7 procedure codes in 2024, for 96 Medicare patients. Medicare paid $13,081 for them. Every service was in an office.

CMS counts 96 Medicare patients who saw Saghi Esfandiarifard in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 72% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Saghi Esfandiarifard's median patient age at 64, with 68% women.

In 2024, Saghi Esfandiarifard wrote 734 Medicare Part D claims for 145 patients. 73% of them were for generic drugs. CMS names the drug for 501 of them, across 19 drugs with 11 or more claims each, at $705,600 in total drug cost.

Saghi Esfandiarifard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Saghi Esfandiarifard as offering telehealth.

Dmand AI links 3 papers to Saghi Esfandiarifard, published from 2017 to 2021. The most frequent topics are Colonic Neoplasms and Veterans. Saghi Esfandiarifard's most frequent co-authors are Pedram Sinai, Ibrahim H. Azar, MD and Gurjiwan Singh Virk, MD.

CMS Open Payments shows 309 general payments to Saghi Esfandiarifard from 49 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 74% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,698.

Saghi Esfandiarifard graduated from St. George's University School of Medicine in 2016.

Saghi Esfandiarifard is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.